Readership
Biomedical Researchers, Epidemiologists, Hematologists, Immunologists, Nurse Oncologists, Oncologists, Physicians - Medicine, Researchers, Residents, Surgical Oncologists, Transplant Surgeons
Scope
Blood Cancer Discovery publishes high-quality Research Articles and Briefs representing major advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. The topics appropriate for coverage include but are not limited to the following: molecular and cellular features of pathogenesis, therapy response and relapse, transcriptional circuits, stem cells, differentiation, microenvironment, metabolism, immunity, mutagenesis, and clonal evolution. These subjects are characterized in animal disease models as well as in high-dimensional clinical data landscapes. The journal welcomes submissions on new pharmacological, biological, and living cell therapies; new diagnostic tools; prognostic, diagnostic, and pharmacodynamic biomarkers; and computational and machine learning approaches to personalized medicine, from preclinical proof of concept to clinical trials and real-world evidence. As a forum for diverse ideas shaping future research directions, the journal will publish Reviews, Perspectives, and Commentaries on topics of broad interest in hematooncology.